Home›Companies›Biotech & Pharma›Pierrepont Therapeutics

Pierrepont Therapeutics, Inc.

Develops treatments for people with primary mitochondrial diseases.

Updated Nov 9, 2026·Latest SEC filing Sep 22, 2026·Suggest an edit

About Pierrepont Therapeutics

Pierrepont Therapeutics is a private company based in Brooklyn, New York. It has reported $2,409,876 raised in one offering on Form D since April 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 2, 2024Apr 15, 2024amended Sep 22, 2026$2,409,876of $5.8M target2$1.2MDebtRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Pierrepont Therapeutics's Form D filed Sep 22, 2026.

Sources

  1. SECPierrepont Therapeutics, Inc. Form D, filed Apr 15, 2024
  2. SECPierrepont Therapeutics, Inc. filing history